福森药业(01652.HK)：二甲双胍恩格列净片拟中选第十一批国家集采
FUSEN PHARMFUSEN PHARM(HK:01652) Ge Long Hui·2025-10-30 09:11

Core Viewpoint - Fosen Pharmaceutical (01652.HK) announced that one of its products, Metformin and Ertugliflozin Tablets (containing 500mg Metformin Hydrochloride and 5mg Ertugliflozin), is expected to win a bid in China's 11th national centralized drug procurement on October 27, 2025 [1] Group 1 - Fosen Pharmaceutical is participating in the 11th round of national drug procurement in China [1] - The product involved in the bidding is a combination of Metformin and Ertugliflozin [1] - The specific formulation includes 500mg of Metformin Hydrochloride and 5mg of Ertugliflozin [1]